The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Developing and Validating Web-Based Clinical Assessments for, 2008Online Motor and Cognitive Analysis System
Objective/Rationale:
Despite advances in treatment approaches to Parkinson’s disease over the past 20 years, patient assessment methods have advanced little during this same period. Therefore, a... -
Developing and Validating Web-Based Clinical Assessments for, 2008A web-based assessment of visual and spatial symptoms in Parkinson's disease
Objective/Rationale:
Problems with visual perception (such as blurry vision or judging distances) are common in people with Parkinson’s disease. Visuospatial impairments are associated with some of... -
Developing and Validating Web-Based Clinical Assessments for, 2008Wearable Sensors and a Web-Based Application to Monitor Patients with Parkinson's Disease in the Home Environment
Objective/Rationale:
Clinicians experience difficulties in adjusting medications in individuals with Parkinson’s disease as the disease progresses and patients experience changes in the severity of... -
Web-Based Clinical Assessment, 2008Developing and Validating Web-based Clinical Assessments for Parkinson's Disease
Objective/Rationale:
Parkinson's disease clinical research traditionally relies on patient recruitment, which can be hindered by the amount of travel a patient must undertake to visit sites for... -
MJFF Research Grant, 2008Validation of Neuroimaging Biomarkers for Nigrostriatal Neurons
Objective/Rationale:
No treatment has been proven to slow progression of Parkinson's disease. To develop such a treatment requires an objective measure of disease progression. Current clinically based... -
Therapeutics Development Initiative, 2008Selective Inhibition of Cyclic Nucleotide Phosphodiesterase Type 7 (PDE7): A Novel and Efficacious Approach to Treating Parkinson's Disease
Objective/Rationale:
Levodopa is the gold standard treatment for Parkinson’s disease. However, its continued use results in serious side effects including abnormal involuntary movements, or...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.